CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

London Regional Cancer Centre, London

Institut De Recherche De L'Hospital D'Ottawa, Ottawa

Princess Margaret Hospital - Toronto, Toronto

Centre Hospitalier de L'Universite de Montreal (CHUM), Montreal

CIUSSS de l'Estrie - CHUS, Sherbrooke

Carmel Medical Center, Haifa

Meir Medical Center, Kfar Saba

Istituto per la Ricerca e la Cura del Cancro Istituto di Candiolo, Candiolo

Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna

Istituto Europeo di Oncologia, Milan

"Istituto Nazionale per lo studio e la cura dei tumori Fondazione Pascale Oncologia Medica", Napoli

Fondazione Policlinico Universitario Agostino Gemelli, Roma

Białostockie Centrum Onkologii im. Marii Skłodowskiej-Curie, Bialystok

Wojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn

Republic Clinical Oncology Dispensary of the Ministry of Healthcare of Republic of Bashkortostan, Ufa

State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Sochi

Arkhangelsk Clinical Oncological Dispensary, Arkhangel'sk

Republican oncological dispensary of Republic of Mordovia, Saransk

Pyatigorsk Oncological Dispensary, Pyatigorsk

N.N. Blokhin Russian Cancer Research Center, Moscow

Omsk Regional Clinical Oncologic Dispensary, Omsk

Ryazan Regional Clinical Oncology Dispensary, Ryazan

Almazov National Medical Research Centre, Saint Petersburg

University College London Hospitals, London

East and North Hertfordshire NHS Trust, Middlesex